European Society of Cell & Gene Therapy
The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.
Festival of Biologics – EU (Basel)
Join 350 world class speakers in exploring the latest research in early stage discovery, modality engineering, translational medicine, clinical trials, manufacturing, commercialisation and fill/finish operations across key therapy and disease areas. With three days of presentations, panels, roundtables and workshops, this event is the place to be to keep up with the latest advances across […]
Show & Tell session 2: Mass photometry AAV analysis demonstration
Looking for a faster method to analyze AAV empty, full, and partial capsids? Join Refeyn for a live virtual demo of the SamuxMP mass photometer — a powerful, single-particle analysis tool for AAV characterization in viral vector research, development, and GMP manufacturing.
BioProcess International Europe
Get exclusive access to the world’s leading bioprocessing experts, groundbreaking discoveries, and industry-defining collaborations. Join us in Hamburg and be part of something extraordinary.
8th Annual Bioprocessing International Summit Europe
Bioprocessing Summit Europe brings together 750+ upstream, downstream, bioproduction, and analytical professionals from industry and academia to advance the manufacture, quality, and control of next generation biologics and genetic therapies. This 3-day, 14-track meeting has quickly become a premier event in the European bioprocessing calendar and focuses on the latest innovations in bioprocess R&D as […]
Advanced Therapies Congress
The Advanced Therapies Congress is Europe’s largest commercial cell and gene therapy conference and exhibition. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. With 10 tracks of content, the agenda covers everything from manufacturing, […]
NextGen Biomed
NextGen Biomed is the biologics drug discovery & development meeting point — uniting six longstanding industry communities on one platform. More than 30,000 biologics and therapeutic R&D experts are enabled to build partnerships, align specialisms, bridge unknowns and commercially convert novel cures into life-changing outcomes for patients.
Innovative Upstream Process Analytical Technologies for Enhanced AAV Manufacturing
Adeno-associated viruses (AAVs) play a crucial role in gene therapy, but producing high-quality vectors at scale remains challenging, particularly due to inefficiencies in DNA packaging. This results in a high proportion of empty or improperly loaded capsids. To address this, Refeyn, Rentschler Biopharma, and the Cell and Gene Therapy Catapult, with support from Innovate UK, […]
De Novo Design of Allosterically Switchable Protein Assemblies
Designing nanodevices that can change shape and function in response to molecular signals is a key objective in protein design, paving the way for the development of switchable nanomaterials, triggerable drug-delivery systems, and molecular motors. In this talk, I will present recent progress in designing and characterizing a diverse range of switchable protein assemblies.
Evaluating Analytical Strategies to Quantify Capsid Titre: Towards a Platform-Method Approach to Accelerate AAV Drug Product Development
Traditional capsid titre methods rely on ELISA which commonly suffers from long turnaround times, low throughput, and large volume sample requirements. This limits the application of ELISA-based methods to routine analysis, thus requiring development of alternative high-throughput (HTP) capsid titre methods. We have performed a comprehensive assessment on currently available orthogonal capsid titre methods using […]
